NYSE$GL
Globe Life Inc · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Globe Life reported its financial results for the fourth quarter ended December 31, 2024, with increases in net income and net operating income per diluted common share compared to the prior year.
Globe Life Inc. reported a net income of $255,196,000 and net operating income of $265,809,000 for the fourth quarter of 2024. Diluted EPS was $3.01, and non-GAAP diluted EPS was $3.14. The company also reported strong performance in its life and health insurance segments, with increased net sales and premiums.
- Net income per diluted common share increased to $3.01 from $2.88 in the year-ago quarter.
- Net operating income per diluted common share rose to $3.14 from $2.80 in the year-ago quarter.
- Life insurance net sales increased 11% for the quarter, and net health sales increased 6%.
- The company repurchased 337,821 shares of common stock at a total cost of $36 million during the quarter.
Headline financials
Revenue & EPS history
Globe Life · Revenue · Quarterly
$1.47B
Revenue by segment
Globe Life · $1.12B total across 2 segments · Q3 2023
- Life Insurance$788M+4.4%70.4%
- Health Insurance$331M+3.7%29.6%
Forward guidance
Globe Life projects net operating income per diluted common share for the year ending December 31, 2025, to be between $13.45 and $14.05.
Tailwinds
- Projected net operating income per diluted common share indicates continued profitability.
- Focus on basic protection life and supplemental health insurance policies generates strong and stable cash flows.
- Sufficient liquidity at the Parent Company to meet additional capital needs of insurance companies.
- Management's use of non-GAAP measures aims to enhance investor understanding and transparency.
- The company's business model is less impacted by volatile equity markets.
Headwinds
- Economic and other conditions, including inflation and geopolitical events, could impact lapse rates, sales, mortality, morbidity, and healthcare utilization.
- Regulatory developments, including changes in accounting standards or governmental regulations, could affect financial results.
- Market trends in the senior-aged health care industry, such as the rise of Health Maintenance Organizations, could affect sales of traditional Medicare Supplement insurance.
- Interest rate changes could impact product sales, financing costs, and investment yields.
- General economic, industry sector, or individual debt issuers' financial conditions could affect the market value of securities and the ability of issuers to make payments.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+0.3%
Avg return
Earnings day
+1.0%
Avg return
5 days after
+1.8%
Avg return
30 days after
51%
37 / 72 earnings
Positive
+13.5%
Q1 2024
Best reaction
-4.6%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.7% | +0.9% | +3.4% | |
| Q4 2025 | +1.5% | -2.0% | -1.8% | |
| Q3 2025 | -0.0% | -0.9% | -2.4% | |
| Q2 2025 | -2.3% | +0.4% | +2.7% | |
| Q1 2025 | -4.6% | -2.4% | -1.2% | |
| Q4 2024 | -2.5% | -1.3% | +2.0% | |
| Q3 2024 | -1.5% | -5.0% | -0.5% | |
| Q2 2024 | -0.5% | +2.8% | +12.6% | |
| Q1 2024 | +13.5% | +13.5% | +28.3% | |
| Q4 2023 | +3.1% | +4.2% | +2.0% | |
| Q3 2023 | +2.0% | +1.9% | +9.0% | |
| Q2 2023 | -2.6% | -1.7% | -2.3% | |
| Q1 2023 | -1.5% | +0.8% | -0.4% | |
| Q4 2022 | -3.4% | +0.5% | -0.2% | |
| Q3 2022 | -2.4% | +0.8% | +2.3% | |
| Q2 2022 | -1.1% | -1.5% | -1.9% | |
| Q1 2022 | +3.1% | -0.6% | -8.9% | |
| Q4 2021 | -0.3% | +1.0% | -5.4% | |
| Q3 2021 | -4.2% | -4.9% | -5.2% | |
| Q2 2021 | -0.2% | +0.8% | +2.0% | |
| Q1 2021 | -1.2% | -0.8% | +2.1% | |
| Q4 2020 | -0.5% | +2.6% | +3.5% | |
| Q3 2020 | +3.6% | +0.5% | +11.8% | |
| Q2 2020 | +6.8% | +5.8% | +7.3% | |
| Q1 2020 | +1.8% | +11.9% | -1.3% | |
| Q4 2019 | +2.8% | +3.0% | -15.0% | |
| Q3 2019 | +0.6% | +0.9% | +5.2% | |
| Q2 2019 | +0.9% | +0.6% | -5.7% | |
| Q1 2019 | +1.9% | -0.0% | +0.3% | |
| Q4 2018 | -1.6% | -2.9% | -2.7% | |
| Q3 2018 | -1.3% | -1.3% | +2.3% | |
| Q2 2018 | +2.7% | +4.3% | +4.6% | |
| Q1 2018 | +2.2% | +1.8% | +0.3% | |
| Q4 2017 | -3.5% | +0.1% | +4.7% | |
| Q3 2017 | +1.1% | +1.5% | +1.8% | |
| Q2 2017 | +0.0% | +0.2% | -1.4% | |
| Q1 2017 | +1.3% | +3.0% | -0.8% | |
| Q4 2016 | +0.2% | +1.2% | +6.3% | |
| Q3 2016 | -0.8% | -0.5% | +11.4% | |
| Q2 2016 | +0.6% | -0.6% | +2.9% | |
| Q1 2016 | +2.3% | — | — | |
| Q4 2015 | -0.7% | — | — | |
| Q3 2015 | -3.8% | — | — | |
| Q2 2015 | -3.7% | — | — | |
| Q1 2015 | +0.2% | — | — | |
| Q4 2014 | +1.8% | — | — | |
| Q3 2014 | -4.4% | — | — | |
| Q2 2014 | -1.5% | — | — | |
| Q1 2014 | +1.2% | — | — | |
| Q4 2013 | -2.9% | — | — | |
| Q3 2013 | -1.9% | — | — | |
| Q2 2013 | +0.4% | — | — | |
| Q1 2013 | +2.4% | — | — | |
| Q4 2012 | -1.8% | — | — | |
| Q3 2012 | -1.3% | — | — | |
| Q2 2012 | -2.6% | — | — | |
| Q1 2012 | -0.4% | — | — | |
| Q4 2011 | -0.4% | — | — | |
| Q3 2011 | -2.9% | — | — | |
| Q2 2011 | -2.7% | — | — | |
| Q1 2011 | +2.1% | — | — | |
| Q4 2010 | +0.3% | — | — | |
| Q3 2010 | -1.0% | — | — | |
| Q2 2010 | +1.2% | — | — | |
| Q1 2010 | +2.5% | — | — | |
| Q4 2009 | +1.6% | — | — | |
| Q4 2007 | +1.6% | — | — | |
| Q3 2009 | +5.2% | — | — | |
| Q3 2008 | +5.2% | — | — | |
| Q2 2009 | +2.5% | — | — | |
| Q2 2008 | +2.5% | — | — | |
| Q4 2008 | +2.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro